Back to today’s briefing

Story perspectives

Cancer Journalist Exposes $1,000 Pill Price Struggle

5/12/2025

47 6

Summary

Story summary

David Armstrong, a journalist, bravely opens up about his fight against cancer and the staggering healthcare costs that accompany it. Diagnosed with multiple myeloma in 2023, he faces the harsh reality of paying $1,000 per pill for Revlimid. His story sheds light on the overwhelming financial strain that countless patients endure in their battle for health.

1 of 1

Story summary

David Armstrong, a journalist, bravely opens up about his fight against cancer and the staggering healthcare costs that accompany it. Diagnosed with multiple myeloma in 2023, he faces the harsh reality of paying $1,000 per pill for Revlimid. His story sheds light on the overwhelming financial strain that countless patients endure in their battle for health.